- Accolade (NASDAQ:ACCD) and Lemonade (NYSE:LMND) on December 29,
- Beam Therapeutics (NASDAQ:BEAM) shares on December 30.
Lilly (LLY) to acquire Prevail Therapeutics for $22.50 per share in cash
** the following day **
OZONFollowing the geopolitical escalation in Ukraine, Ozon Holdings PLC was officially delisted from the Nasdaq. While the core business has continued to operate and grow within its regional markets, its structural relationship with international equity markets shifted entirely.
** charts after earnings **
Warner Music Group Corp. reported Monday a breakeven fiscal fourth quarter, missing expectations, although revenue rose slightly above forecasts. The stock rose 0.8% in premarket trading. Net income for the quarter to Sept. 30 fell to $1 million, or $0.00 on a per-share basis, from $91 million, or 18 cents a share, in the year-ago period. The FactSet consensus for net earnings per share was 5 cents. Adjusted net income, which excludes non-recurring items related to the initial public offering, fell to $20 million from $125 million. Revenue rose 0.2% to $1.13 billion, just above the FactSet consensus of $1.11 billion, as "robust" digital revenue growth was partially offset by a decline in recorded music artist services, and the effects of the COVID-19 pandemic on its music publishing business. "We're essentially flat against a record-breaking prior year and, during the quarter, we grew 11% on an as-reported basis, excluding the revenue streams most impacted by COVID," said Chief Executive Steve Cooper. "Our streaming growth has stayed strong, and we've also seen an acceleration in a whole spectrum of emerging revenue streams such as social media, gaming, and in-home fitness." The stock has lost 3.7% over the past three months through Friday, while the S&P 500 has gained 4.7%.
** charts after earnings **
Workday beats by $0.19, beats on revs, raises FY21 subscription revenue guidance
Telos upsized and priced previously announced IPO of 14,968,859 shares of common stock at a price of $17.00 per share